2931 related articles for article (PubMed ID: 33228350)
41. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
42. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA.
Solares C; Velasco J; Álvarez-Ruiz E; González-Fernández L; Encinas AI; Astudillo A; Schneider J
Anticancer Res; 2015 Nov; 35(11):6291-5. PubMed ID: 26504065
[TBL] [Abstract][Full Text] [Related]
43. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
Zhan X; Wang S; Wu X; Qiu X; Li F; Zeng Y; Chen Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
[TBL] [Abstract][Full Text] [Related]
44. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
ASCUS-LSIL Traige Study (ALTS) Group
Am J Obstet Gynecol; 2003 Jun; 188(6):1383-92. PubMed ID: 12824967
[TBL] [Abstract][Full Text] [Related]
45. p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China.
Liao GD; Sellors JW; Sun HK; Zhang X; Bao YP; Jeronimo J; Chen W; Zhao FH; Song Y; Cao Z; Zhang SK; Xi MR; Qiao YL
Int J Cancer; 2014 Apr; 134(7):1715-24. PubMed ID: 24105727
[TBL] [Abstract][Full Text] [Related]
46. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
47. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear.
Bose S; Evans H; Lantzy L; Scharre K; Youssef E
Diagn Cytopathol; 2005 Jan; 32(1):21-4. PubMed ID: 15584047
[TBL] [Abstract][Full Text] [Related]
48. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
49. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
50. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
51. [Performance of vaginal self-sampling high-risk HPV genotyping as primary and combining cytology or viral load as secondary in cervical cancer screening].
Guo CL; Luo HX; Wang C; Qu XF; Yang B; Belinson JL; Du H; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2021 Apr; 56(4):271-279. PubMed ID: 33902239
[No Abstract] [Full Text] [Related]
52. Clinical evaluation of p16
Rezhake R; Wang Y; Chen F; Hu SY; Zhang X; Cao J; Qiao YL; Zhao FH; Arbyn M
Cancer Cytopathol; 2021 Sep; 129(9):679-692. PubMed ID: 33826790
[TBL] [Abstract][Full Text] [Related]
53. Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study.
Genovés J; Alameda F; Mancebo G; Solé JM; Bellosillo B; Lloveras B; Agramunt S; Baró MT; Muset M; Casado B; Serrano L; Miralpeix E; Carreras R
Hum Pathol; 2014 Apr; 45(4):826-33. PubMed ID: 24656093
[TBL] [Abstract][Full Text] [Related]
54. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening].
Xu T; Lu HJ; He YF
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939
[TBL] [Abstract][Full Text] [Related]
55. [The usefulness of p16INK4a in cytological screening of cervical carcinoma].
Li M; Cao J; Wang NP; Li LY; Li L; Qiao YL; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):674-7. PubMed ID: 17274373
[TBL] [Abstract][Full Text] [Related]
56. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
Uijterwaal MH; Polman NJ; Witte BI; van Kemenade FJ; Rijkaart D; Berkhof J; Balfoort-van der Meij GA; Ridder R; Snijders PJ; Meijer CJ
Int J Cancer; 2015 May; 136(10):2361-8. PubMed ID: 25345358
[TBL] [Abstract][Full Text] [Related]
57. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
[TBL] [Abstract][Full Text] [Related]
58. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
59. Immunocytochemical staining of p16(ink4a) protein as an adjunct test in equivocal liquid-based cytology.
Shin EK; Lee SR; Kim MK; Kang EJ; Ju W; Lee SN; Han WS; Kim SC
Diagn Cytopathol; 2008 May; 36(5):311-6. PubMed ID: 18418881
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of p16
Song F; Belinson JL; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
Gynecol Oncol; 2021 Aug; 162(2):322-330. PubMed ID: 34059349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
